BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34983609)

  • 1. A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities.
    Montes J; Eichinger KJ; Pasternak A; Yochai C; Krosschell KJ
    Orphanet J Rare Dis; 2022 Jan; 17(1):5. PubMed ID: 34983609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular monitoring devices - where to go next?
    Damian MS
    Curr Opin Neurol; 2021 Oct; 34(5):721-726. PubMed ID: 34267050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemedicine applied to neuromuscular disorders: focus on the COVID-19 pandemic era.
    Giannotta M; Petrelli C; Pini A
    Acta Myol; 2022 Mar; 41(1):30-36. PubMed ID: 35465343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curricular response to COVID-19: real-time interactive telehealth experience (RITE) program.
    Safdieh JE; Lee JI; Prasad L; Mulcare M; Eiss B; Kang Y
    Med Educ Online; 2021 Dec; 26(1):1918609. PubMed ID: 33886434
    [No Abstract]   [Full Text] [Related]  

  • 5. An outpatient telehealth elective for displaced clinical learners during the COVID-19 pandemic.
    Weber AM; Dua A; Chang K; Jupalli H; Rizwan F; Chouthai A; Chen C
    BMC Med Educ; 2021 Mar; 21(1):174. PubMed ID: 33743676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic.
    Costamagna G; Abati E; Bresolin N; Comi GP; Corti S
    J Neurol; 2021 May; 268(5):1580-1591. PubMed ID: 32804279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to define and enhance diagnostic and assistance pathways in neuromuscular diseases during the COVID-19 pandemic: the concept of network.
    Astrea G; Marinella G; Agosto C; Gagliardi D; Grandis M; Giuliano M; Politano L
    Acta Myol; 2021 Dec; 40(4):172-176. PubMed ID: 35047757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Technological Impact of COVID-19 on the Future of Education and Health Care Delivery.
    Shah S; Diwan S; Kohan L; Rosenblum D; Gharibo C; Soin A; Sulindro A; Nguyen Q; Provenzano DA
    Pain Physician; 2020 Aug; 23(4S):S367-S380. PubMed ID: 32942794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic.
    James MK; Rose K; Alfano LN; Reash NF; Eagle M; Lowes LP
    Front Genet; 2021; 12():735538. PubMed ID: 34790223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic.
    Moon SJE; Dabbs AD; Hergenroeder AL; Vendetti ML; Jones KB; Willey BM; Morrell MR; Imes CC
    Contemp Clin Trials; 2021 Jun; 105():106407. PubMed ID: 33887443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home Care Delivery and Remote Patient Monitoring of Kidney Transplant Recipients During COVID-19 Pandemic.
    Chang JH; Sritharan S; Schmitt K; Patel S; Crew RJ; Tsapepas DS
    Prog Transplant; 2021 Dec; 31(4):381-384. PubMed ID: 34677108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitioning to telehealth neuropsychology service: Considerations across adult and pediatric care settings.
    Hewitt KC; Rodgin S; Loring DW; Pritchard AE; Jacobson LA
    Clin Neuropsychol; 2020; 34(7-8):1335-1351. PubMed ID: 32842849
    [No Abstract]   [Full Text] [Related]  

  • 13. New patient access via telehealth in neuromuscular medicine during COVID-19.
    Khan S; Kramer A; McIver J; Cady L; Trivedi JR
    Work; 2021; 69(3):715-719. PubMed ID: 34180450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teleneurology in a center for neuromuscular diseases during the COVID-19 pandemic.
    Spiliopoulos KC; Kasdaglis N; Veltsista D; Lykouras D; Lagadinou M; Chroni E
    Acta Neurol Belg; 2022 Jun; 122(3):721-724. PubMed ID: 34585321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to manage with telemedicine people with neuromuscular diseases?
    Spina E; Trojsi F; Tozza S; Iovino A; Iodice R; Passaniti C; Abbadessa G; Bonavita S; Leocani L; Tedeschi G; Manganelli F; Lavorgna L;
    Neurol Sci; 2021 Sep; 42(9):3553-3559. PubMed ID: 34173087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' Experiences of Remote Neurology Consultations during the COVID-19 Pandemic.
    McKenna MC; Al-Hinai M; Bradley D; Doran E; Hunt I; Hutchinson S; Langan Y; O'Rourke D; Qasem R; Redmond J; Troy E; Doherty CP
    Eur Neurol; 2020; 83(6):622-625. PubMed ID: 33147591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How, when, and for whom: decisions regarding remote neuropsychological assessment during the 2020 COVID-19 pandemic.
    Bloch A; Maril S; Kavé G
    Isr J Health Policy Res; 2021 May; 10(1):31. PubMed ID: 33941268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The patient's perspective of remote respiratory assessments during the COVID-19 pandemic.
    Tattersall R; Carty S; Meldrum D; Hardiman O; Murray D
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Feb; 23(1-2):76-80. PubMed ID: 34092157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual models of chronic disease management: lessons from the experiences of virtual care during the COVID-19 response.
    Smithson R; Roche E; Wicker C
    Aust Health Rev; 2021 Jun; 45(3):311-316. PubMed ID: 33583487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of telehealth in home nutrition support: Challenges and advantages.
    Mundi MS; Mohamed Elfadil O; Bonnes SL; Salonen BR; Hurt RT
    Nutr Clin Pract; 2021 Aug; 36(4):775-784. PubMed ID: 34245465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.